p53

Open Access
Improved Analysis of Prostate Cancer: VIM3, ATG7 and P53 Form a Complex and Activate miRNA 371a-3p
ELENA K. NOHL, JASMIN BEHRING, ERSEN KAMERI, BARBARA KÖDITZ, TIM NESTLER, AXEL HEIDENREICH and MELANIE VON BRANDENSTEIN

Anticancer Research June 2023, 43 (6) 2407-2416; DOI: https://doi.org/10.21873/anticanres.16408
You have access
Arsenite-induced Radiosensitization of Glioma Cells Is Dependent on p53 Deficiency
YASUHARU NINOMIYA, TATSUHIKO IMAOKA, KAZUHIRO DAINO, SHIZUKO KAKINUMA and TETSUO NAKAJIMA

Anticancer Research June 2023, 43 (6) 2551-2559; DOI: https://doi.org/10.21873/anticanres.16422
You have access
5-Azacytidine (5-aza) Induces p53-associated Cell Death Through Inhibition of DNA Methyltransferase Activity in Hep3B and HT-29 Cells
DAE-YEON KIM, RANGYEON LEE, HEE-TAE CHEONG, CHANG-SIX RA, KI-JONG RHEE, JEONGHO PARK and BAE DONG JUNG

Anticancer Research February 2023, 43 (2) 639-644; DOI: https://doi.org/10.21873/anticanres.16200
You have access
Lymph-vascular Space Involvement and/or p53 Overexpression Correlated With the Clinical Outcome of Early-stage Endometrial Cancer Patients Treated With Adjuvant Vaginal Brachytherapy
CONCETTA LALISCIA, ANGIOLO GADDUCCI, NATALINA COCCIA, ROBERTO MATTIONI, TAIUSHA FUENTES, MARTA CARETTO, SABINA PISTOLESI, PAOLA PUCCINI, FRANCO PERRONE, RICCARDO MORGANTI and FABIOLA PAIAR

Anticancer Research January 2023, 43 (1) 149-156; DOI: https://doi.org/10.21873/anticanres.16144
You have access
Clinicopathological Characteristics of Advanced Epstein–Barr Virus-associated Gastric Cancer Highlighting Aberrant p53 Expression
HYEONGUK JANG, AN NA SEO and MOONSIK KIM

Anticancer Research October 2022, 42 (10) 4955-4962; DOI: https://doi.org/10.21873/anticanres.16002
You have access
Molecular Characteristics of Metastatic Lesions Have Superior Prognostic Impact on Endometrial Cancer
KAZUHIRO OKAMOTO, KEIICHIRO NAKAMURA, JUNKO HARAGA and HISASHI MASUYAMA

Anticancer Research September 2022, 42 (9) 4535-4543; DOI: https://doi.org/10.21873/anticanres.15956
You have access
Murine Double Minute 2 Antagonist Nutlin-3 Enhanced Chemosensitivity in Esophageal Squamous Cell Carcinoma
KEN ITO, HIROTAKA ISHIDA, FUMIYOSHI FUJISHIMA, YASUHIRO NAKAMURA, TAKURO KONNO, KAZUE ISE, SHUKO HATA, YOHEI OZAWA, YUSUKE TANIYAMA, TAKASHI KAMEI and HIRONOBU SASANO

Anticancer Research June 2022, 42 (6) 2875-2882; DOI: https://doi.org/10.21873/anticanres.15769
You have access
Reactivation of p53 by RITA Induces Apoptosis in Human Oral Squamous Cell Carcinoma Cells
MANABU ENDO, TAKASHI NISHIOKA, KENTO NUMAZAKI, HIROSHI HASEGAWA, TETSU TAKAHASHI, SHUNJI SUGAWARA and HIROYUKI TADA

Anticancer Research June 2022, 42 (6) 2931-2937; DOI: https://doi.org/10.21873/anticanres.15775
Open Access
The Effect of Asparagus Extract on Pancreatic Cancer: An Intriguing Surprise
HUAPING XIAO, ZULIANG DENG, JACOB T. HOUGH, XUHUI CHEN, ZIWEN ZHU, JACOB LEE, ALDO DOMINGUEZ, TIANRU SHI, JOSEPH SCHMIDT, QIAN BAI, MARK R. WAKEFIELD and YUJIANG FANG

Anticancer Research May 2022, 42 (5) 2425-2432; DOI: https://doi.org/10.21873/anticanres.15721
You have access
Azoxystrobin Induces Apoptosis and Cell Cycle Arrest in Human Leukemia Cells Independent of p53 Expression
SHUNSUKE TAKAHASHI, TAKAHISA SHINOMIYA and YUKITOSHI NAGAHARA

Anticancer Research March 2022, 42 (3) 1307-1312; DOI: https://doi.org/10.21873/anticanres.15598

Main menu

User menu

Search

p53

Pages